遂宁市中心医院2006~2022年常见非感染性肝病分布特征及变化趋势分析

Distributed feature and changing trend of non-infectious liver diseases in Suining Central Hospital from 2006 to 2022

目的对遂宁市中心医院2006~2022年常见非感染性肝病分布特征及变化趋势进行回顾性分析。方法收集2006~2022年遂宁市中心医院因肝脏疾病入院患者的病案首页资料,分析该院住院患者非感染性肝病患者的年龄、性别等分布特征,以及非感染性肝病患者在总肝脏疾病住院患者中的构成比及变化趋势。结果4种非感染性肝病患者中,除了自身免疫性肝病女性患者多于男性患者,其余三种非感染性肝病均男性患者多于女性患者。4种非感染性肝病的发病年龄主要集中在41~65岁,构成比为55.59%~72.69%;酒精性肝病患者最多,构成比为34.32%;其次是非酒精性脂肪性肝病患者,构成比为25.30%;自身免疫性肝病患者最少,构成比为17.07%。2006~2022年,4种非感染性肝病占总肝脏疾病住院患者的构成比呈逐年增高的趋势。结论酒精性肝病、药物性肝损伤、自身免疫性肝病、非酒精性脂肪性肝病在我院总肝脏疾病住院患者中的构成比呈逐年升高的趋势,我院应建立肝病多学科综合治疗,整合多学科资源,使非感染性肝病的诊断治疗进入新的阶段。

Objective Retrospective analysis was conducted to invest the distributed feature and changing trend of non-infectious liver diseases in Suining Central Hospital from 2006 to 2022.Methods Medical records were collected from hospitalized patients with liver diseases in Suining Central Hospital from 2006 to 2022.Beside the distributed feature of age and gender,constituent ratio and changing trend of non-infectious liver diseases were analyzed.Results Among the four non-infectious liver disease,the percentage of female with autoimmune liver diseases was higher than male.The percentage of male were higher than female in other three non-infectious liver diseases.The incidence rate of non-infectious liver diseases in 41-65 years old people was highest,and the constituent ratio was 55.59%to 72.69%.The constituent ratio of alcoholic liver disease was highest(34.32%),followed by non-alcoholic fatty liver disease(25.30%).The constituent ratio of autoimmune liver disease was lowest(17.07%).The proportion of patients with non-infectious liver disease among the hospitalized patients with liver diseases tended to increase from 2006 to 2022.Conclusion The proportion of patients with autoimmune liver disease,non-alcoholic fatty liver disease,drug-induced liver injury and alcoholic liver disease among the hospitalized patients with liver diseases tended to increase year by year in Suining Central Hospital.Multi-disciplinary comprehensive treatment must be conducted on non-infectious liver diseases to enable the diagnosis and treatment of non-infectious liver disease into a new stage.